- Home
- KPTI vs GTEC Comparison
KPTI vs GTEC Comparison
Compare KPTI & GTEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPTI
- GTEC
- Stock Information
- Founded
- KPTI 2008
- GTEC 2006
- Country
- KPTI United States
- GTEC United States
- Employees
- KPTI N/A
- GTEC N/A
- Industry
- KPTI Biotechnology: Pharmaceutical Preparations
- GTEC Industrial Machinery/Components
- Sector
- KPTI Health Care
- GTEC Industrials
- Exchange
- KPTI Nasdaq
- GTEC Nasdaq
- Market Cap
- KPTI 44.5M
- GTEC 21.2M
- IPO Year
- KPTI 2013
- GTEC N/A
- Fundamental
- Price
- KPTI $7.11
- GTEC $1.39
- Analyst Decision
- KPTI Buy
- GTEC
- Analyst Count
- KPTI 6
- GTEC 0
- Target Price
- KPTI $39.80
- GTEC N/A
- AVG Volume (30 Days)
- KPTI 218.0K
- GTEC 305.6K
- Earning Date
- KPTI 08-11-2025
- GTEC 08-13-2025
- Dividend Yield
- KPTI N/A
- GTEC N/A
- EPS Growth
- KPTI N/A
- GTEC N/A
- EPS
- KPTI N/A
- GTEC 0.53
- Revenue
- KPTI $137,269,000.00
- GTEC $81,601,160.00
- Revenue This Year
- KPTI $3.67
- GTEC $3.28
- Revenue Next Year
- KPTI $9.40
- GTEC N/A
- P/E Ratio
- KPTI N/A
- GTEC $2.62
- Revenue Growth
- KPTI N/A
- GTEC N/A
- 52 Week Low
- KPTI $3.51
- GTEC $1.14
- 52 Week High
- KPTI $16.95
- GTEC $2.94
- Technical
- Relative Strength Index (RSI)
- KPTI 66.00
- GTEC 40.99
- Support Level
- KPTI $6.02
- GTEC $1.31
- Resistance Level
- KPTI $8.15
- GTEC $1.45
- Average True Range (ATR)
- KPTI 0.74
- GTEC 0.10
- MACD
- KPTI 0.24
- GTEC 0.03
- Stochastic Oscillator
- KPTI 76.42
- GTEC 58.14
About KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. XPOVIO (selinexor), is approved in the U.S. in multiple hematologic malignancy indications, including in combination with Velcade (bortezomib) and dexamethasone for the treatment of adult patients with multiple myeloma after at least one prior therapy, in combination with dexamethasone for the treatment of adult patients with heavily pretreated multiple myeloma and as a monotherapy for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma. The company derives its revenue from United States.
About GTEC Greenland Technologies Holding Corporation
Greenland Technologies Holding Corp is a developer of quality solutions in the material handling industry. It is a transmission and drivetrain systems provider for material handling equipment such as forklift trucks for industrial and logistic applications. Geographically, the company has its presence in Domestic and International markets and earns majority of the revenue from Domestic Sales.